Specifically, MRE11 deficiency is associated with improved overall survival (OS) and long-term disease-free survival (DFS) in patients with stage III colon cancer independent of treatment [10], suggesting that MRE11 status has value as a prognostic marker in CRC. The gene discussed is MRE11; the disease is colonic neoplasm.